本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

41.67
+0.68001.66%
盘后41.670.00000.00%16:43 EST
成交量:33.95万
成交额:1,410.60万
市值:31.58亿
市盈率:89.26
高:42.00
开:41.12
低:40.31
收:40.99
52周最高:42.98
52周最低:17.82
股本:7,579.58万
流通股本:3,524.44万
量比:1.31
换手率:0.96%
股息:- -
股息率:- -
每股收益(TTM):0.4668
每股收益(LYR):-0.6047
净资产收益率:7.39%
总资产收益率:3.76%
市净率:5.90
市盈率(LYR):-68.91

数据加载中...

2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/28

重要事件披露

Form 8-K - Current report
2025/10/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/03

重要事件披露

Form 8-K - Current report
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities